共 343 条
[1]
Bergamasco A(2019)Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease Clin Epidemiol 11 257-273
[2]
Hartmann N(2010)Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database Ann Rheum Dis 69 1809-1815
[3]
Wallace L(2013)2013 Classification criteria for systemic sclerosis: an American college of rheumatology/european league against rheumatism collaborative initiative Arthritis Rheum 65 2737-2747
[4]
Verpillat P(2015)Performance of the new ACR/EULAR classification criteria for systemic sclerosis in clinical practice Rheumatology (Oxford) 54 1454-1458
[5]
Tyndall AJ(2020)Systemic sclerosis-associated interstitial lung disease Lancet Respir Med 8 304-320
[6]
Bannert B(2020)Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: derivation and internal validation Autoimmun Rev 19 102507-695
[7]
Vonk M(2019)Cardiovascular complications of systemic sclerosis: what to look for Clevel Clin J Med 86 685-1635
[8]
Airò P(2014)Prediction of pulmonary complications and long-term survival in systemic sclerosis Arthritis Rheumatol 66 1625-2298
[9]
Cozzi F(2010)Prevalence of pulmonary hypertension in systemic sclerosis in European Caucasians and metaanalysis of 5 studies J Rheumatol 37 2290-37
[10]
Carreira PE(2011)Pulmonary hypertension in systemic sclerosis Semin Arthritis Rheum 41 19-1349